Unknown

Dataset Information

0

Human Epidermal Growth Factor Receptor 2-Low Breast Cancer: Prevalence Rate and Scoring Concordance Among Pathologists

ABSTRACT:

SUBMITTER: Sughayer M 

PROVIDER: S-EPMC12371226 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Accuracy of human epidermal growth factor receptor 2 (HER2) immunohistochemistry scoring by pathologists in breast cancer, including the HER2-low cutoff : HER2 IHC scoring concordance in breast cancer.
| S-EPMC11969812 | biostudies-literature
Unknown Diagnostic concordance among pathologists interpreting breast biopsy specimens.
| S-EPMC4516388 | biostudies-literature
Unknown Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists.
| S-EPMC6629520 | biostudies-literature
Unknown Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland -on behalf of the UK national coordinating committee for breast pathology.
| S-EPMC10382984 | biostudies-literature
Unknown Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
| S-EPMC4086638 | biostudies-literature
Unknown Role of epidermal growth factor receptor in breast cancer.
| S-EPMC3832208 | biostudies-literature
Unknown Cost-effectiveness of trastuzumab deruxtecan in previously treated human epidermal growth factor receptor 2-low metastatic breast cancer.
| S-EPMC10204055 | biostudies-literature
Unknown Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
| S-EPMC3076082 | biostudies-literature
Unknown Therapeutic Landscape of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
| S-EPMC9067050 | biostudies-literature
Unknown FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer.
| S-EPMC8742024 | biostudies-literature